Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Invested Capital (2016 - 2026)

Apyx Medical filings provide 16 years of Invested Capital readings, the most recent being $14.6 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 71.89% to $14.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.6 million, a 71.89% decrease, with the full-year FY2025 number at $14.6 million, down 71.89% from a year prior.
  • Invested Capital hit $14.6 million in Q4 2025 for Apyx Medical, down from $43.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $64.4 million in Q4 2023 to a low of $14.6 million in Q4 2025.
  • Median Invested Capital over the past 5 years was $48.3 million (2024), compared with a mean of $47.7 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 69.97% in 2023 and later crashed 71.89% in 2025.
  • Apyx Medical's Invested Capital stood at $54.2 million in 2021, then plummeted by 30.06% to $37.9 million in 2022, then skyrocketed by 69.97% to $64.4 million in 2023, then decreased by 19.54% to $51.8 million in 2024, then crashed by 71.89% to $14.6 million in 2025.
  • The last three reported values for Invested Capital were $14.6 million (Q4 2025), $43.6 million (Q3 2025), and $45.0 million (Q2 2025) per Business Quant data.